Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 6.2B | 6.0B | 6.4B | 5.8B |
Cost of revenue | 2.9B | 3.0B | 3.1B | 2.9B |
Gross profit | 3.2B | 3.0B | 3.3B | 3.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 746M | 8.8B | 724M | 707M |
Other operating expenses | 1.9B | -5.9B | 2.1B | 1.9B |
Operating income | 609M | 11M | 596M | 347M |
Non operating interest income | ||||
Income | 34M | -14M | 29M | 20M |
Expense | 59M | 20M | 25M | 62M |
Other income expense | — | — | — | — |
Pretax income | 585M | -29M | 601M | 304M |
Tax provision | 149M | -2M | 133M | 93M |
Net income | 429M | -19M | 476M | 206M |
Basic EPS | — | — | 2.5 | 1.1 |
Diluted EPS | — | — | 2.5 | 1.1 |
Basic average shares | — | — | 178.6M | 179.2M |
Diluted average shares | — | — | 178.6M | 179.2M |
EBITDA | 926M | 292M | 936M | 653M |
Net income from continuing op. | 585M | -29M | 601M | 304M |
Minority interests | -1M | -20M | -33M | -16M |
Preferred stock dividends | 0 | 0 | 0 | 0 |